Thea Mulder‐Krieger

Author

Thea Mulder‐Krieger

Centre for Human Drug Research

Also Known As

Thea Mulder-Krieger, Thea Mulder‐Krieger

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Centre for Human Drug Research Leiden University Janssen (Belgium)University of Cambridge Unilever (United Kingdom)

About

Thea Mulder‐Krieger is an author at Centre for Human Drug Research specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	671
2	Biochemistry	11	12	636
3	Natural Sciences	5	5	405
4	Engineering	1	1	35
5	Molecular Biology	1	1	114

Thea Mulder‐Krieger

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Functional efficacy of adenosine A<sub>2A</sub>receptor agonists is positively correlated to their receptor residence time Dong Guo, Thea Mulder‐Krieger, Adriaan P. IJzerman, British Journal of Pharmacology	2012	183
New, Non-Adenosine, High-Potency Agonists for the Human Adenosine A<sub>2B</sub> Receptor with an Improved Selectivity Profile Compared to the Reference Agonist <i>N</i>-Ethylcarboxamidoadenosine Margot W. Beukers, Lisa C. W. Chang, Jacobien K. von Frijtag Drabbe Künzel, Journal of Medicinal Chemistry	2004	150
Predicting Binding Affinities for GPCR Ligands Using Free-Energy Perturbation Eelke B. Lenselink, Julien Louvel, Anna F. Forti, ACS Omega	2016	145
2-Amino-6-furan-2-yl-4-substituted Nicotinonitriles as A<sub>2A</sub> Adenosine Receptor Antagonists Monica Mantri, Olivier de Graaf, Jacobus van Veldhoven, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryA 2AMedicine	2008	144
A Series of Ligands Displaying a Remarkable Agonistic−Antagonistic Profile at the Adenosine A<sub>1</sub> Receptor Lisa C. W. Chang, Jacobien K. von Frijtag Drabbe Künzel, Thea Mulder‐Krieger, Journal of Medicinal Chemistry Molecular PharmacologyBiochemistryFunctional SelectivityMedicineAdenosine A	2004	114
2,4,6-Trisubstituted Pyrimidines as a New Class of Selective Adenosine A<sub>1</sub> Receptor Antagonists Lisa C. W. Chang, Ronald F. Spanjersberg, Jacobien K. von Frijtag Drabbe Künzel, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryAdenosine ReceptorsBiochemistryFunctional Selectivity	2004	94
Dual-Point Competition Association Assay: A Fast and High-Throughput Kinetic Screening Method for Assessing Ligand-Receptor Binding Kinetics Dong Guo, Erika J.H. van Dorp, Thea Mulder‐Krieger, SLAS DISCOVERY	2012	65
A Series of 2,4-Disubstituted Quinolines as a New Class of Allosteric Enhancers of the Adenosine A<sub>3</sub>Receptor Laura H. Heitman, Anikó Göblyös, Annelien J.M. Zweemer, Journal of Medicinal Chemistry	2009	62
Identifying Novel Adenosine Receptor Ligands by Simultaneous Proteochemometric Modeling of Rat and Human Bioactivity Data Gerard J. P. van Westen, Olaf O. van den Hoven, Rianne van der Pijl, Journal of Medicinal Chemistry	2012	53
The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptor J. Robert Lane, Margot W. Beukers, Thea Mulder‐Krieger, Biochemical Pharmacology Cannabis UseMolecular PharmacologySignal TransductionBiochemistryG Protein-coupled Receptor	2009	48

Page 1